Skip to main content
· 4 min read

Validation Software for Biotech Companies: What to Look for in 2026

Validation Software for Biotech Companies: What to Look for in 2026

Biotech companies operate under the same GxP obligations as large pharma — but with faster timelines, leaner teams, and systems that change constantly. Generic document tools and spreadsheets create inspection exposure, not compliance. A purpose-built validation platform is how scaling biotechs stay audit-ready without burning their team on manual paperwork.

Why Biotech Validation Is Different

Biological processes — cell line development, bioreactor control, chromatography, LIMS, MES — involve complex, high-risk computerised systems that evolve rapidly as science advances. Every change to a validated system triggers documented impact assessment, retesting, and re-approval. Without a platform built to manage that lifecycle, teams fall back on email, shared drives, and manual trackers — and inspection findings follow.

Rapid System Turnover

Biotech systems update faster than pharma. Your validation platform needs built-in change control, not a separate process bolted on afterward.

Scale-Up Pressure

From IND to BLA, your compliance infrastructure must scale without rebuilding. A VLMS grows with you — paper doesn't.

Lean Validation Teams

Most biotechs can't staff dedicated validation headcount at every site. The platform must automate what people would otherwise do manually.

Multi-System Complexity

LIMS, MES, ERP, ELN — all GxP relevant, all requiring parallel validation lifecycles managed consistently.

Purpose-Built VLMS vs Generic Document Tools

CapabilityGeneric DMS / SharePointGoVal (Purpose-Built VLMS)
21 CFR Part 11 e-signaturesConfiguration required, often incompleteNative, architecture-level
Live RTM generationManual spreadsheet maintained separatelyAutomatic, linked at test creation
GAMP 5 workflowsNot present — built by hand each timeBuilt in, category-adaptive
Change control integrationSeparate process, manual linkingIntegrated — linked to parent protocols
VSR / report generationManual compilation — hours per reportOne-click, audit-ready output
Platform validation statusRequires separate CSV project firstPre-validated — IQ/OQ/PQ docs included
About 26% of life sciences companies still use paper or spreadsheets for validation — primarily startups and scale-ups that underestimate what's required at inspection. The cost isn't visible until a Form 483 arrives.

What GoVal Covers Across the Biotech Validation Lifecycle

Validation PhaseGoVal functionality
System inventoryCentralised GxP system register with GAMP 5 categorisation, risk rating, and validation status per system.
URS / FRS authoringStructured requirement authoring with automatic linking to test cases — RTM is live from day one.
IQ / OQ / PQ executionElectronic test execution with pass/fail capture, inline deviation raising, and e-signature at each step.
Deviation managementDeviations raised mid-execution are formally tracked with impact assessment and CAPA — not a notebook entry.
Change controlChanges assessed against validated state, retesting scope determined, and re-approval fully documented.
Periodic reviewScheduled reviews triggered automatically — never missed because someone forgot a calendar entry.
VSR generationComplete Validation Summary Report generated in minutes — ready for regulatory submission or inspection.

Frequently Asked Questions

What is the best validation software for biotech companies?
GoVal is purpose-built validation lifecycle management software for biotech and pharma companies. It covers the full GxP validation lifecycle — system inventory, GAMP 5 categorisation, URS authoring, IQ/OQ/PQ execution, live automatic RTM, deviation management, change control, periodic review, and one-click VSR generation — all in a single pre-validated platform with native 21 CFR Part 11 e-signatures. GoVal deploys in 4–8 weeks, with no separate CSV project needed to get started.
Do biotech startups need computer system validation software?
Yes. Any biotech in a GxP environment — including clinical-stage companies — must validate computerised systems that affect product quality, data integrity, or patient safety. GoVal is built to scale from first IND through BLA, so you're not rebuilding your compliance infrastructure at each regulatory milestone. It comes pre-validated with its own IQ/OQ/PQ documentation, so you're working in a compliant environment from day one.
What validation software supports FDA 21 CFR Part 11 compliance for biotech?
GoVal has native 21 CFR Part 11 compliance built into its core architecture. This includes electronic signatures that capture signer identity, date/time, and meaning with credential re-entry per signing event; computer-generated tamper-evident audit trails on all record changes; and unique user accounts with role-based access controls. These are system-level controls — not configurable options that could be switched off or misconfigured.
What is the difference between CSV and CSA for biotech validation?
Computer System Validation (CSV) is the traditional documentation-heavy approach. Computer Software Assurance (CSA), finalised by FDA in 2025, is a risk-proportionate alternative that reduces unnecessary documentation while maintaining rigour for high-risk systems. GoVal supports both and automatically adjusts evidence requirements based on each system's GAMP 5 category — so you don't over-document low-risk systems or under-document critical ones.
Which validation software supports GAMP 5 workflows for life sciences?
GoVal supports GAMP 5 Second Edition natively. It categorises each system (Categories 1–5), automatically calibrates validation depth and required documentation based on category and risk rating, and adapts testing scope accordingly. GAMP 5 categorisation is captured at system registration and flows through every downstream activity — from URS authoring through periodic review — without manual reconfiguration at each phase.
How long does computer system validation take with validation software?
Paper-based CSV for a Category 4 or 5 system typically takes 3–6 months from URS to VSR. With GoVal, the same process — protocol authoring, IQ/OQ/PQ execution, deviation management, and VSR generation — completes in 4–8 weeks. The largest time savings come from automatic live RTM generation and one-click VSR compilation, which eliminate weeks of manual document assembly that stall every paper-based project.

Built for Biotech. Ready for Inspection.

GoVal covers your full validation lifecycle — from system registration to VSR — in one pre-validated platform designed for the pace of biotech.

Book a Free Demo →